Chemokines and chemokine receptors in renal pathology

Current Opinion in Nephrology and Hypertension

Volumn 12, Issue 3, 2003, Pages 243-249

  Segerer, Stephan ^a   Alpers, Charles E ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chemokine receptor; Chemokines; Glomerulonephritis; Interstitial fibrosis; Transplant rejection

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE;

ANIMAL MODEL; CELL INFILTRATION; CELL INTERACTION; DISEASE COURSE; GENE EXPRESSION; GENETIC VARIABILITY; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMAN; INFLAMMATORY CELL; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LYMPHOPOIESIS; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; CHEMOKINES; GENE EXPRESSION; HUMANS; KIDNEY; KIDNEY DISEASES; RECEPTORS, CHEMOKINE;

EID: 0037614847     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200305000-00004     Document Type: Review

References (50)

1. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52:145-176.
2. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001; 250:91-104.
3. Middleton J, Patterson AM, Gardner L, et al. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002; 100:3853-3860. This provides an excellent overview about the presentation of chemokines on the endothelial surface.
4. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11:152-176.
5. Muller G, Hopken UE, Stein H, Lipp M. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 2002; 72:1-8. This is an excellent review of the importance of CXCR5 and CCR7.
6. Banas B, Wornle M, Berger T, et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 2002; 168:4301-4307. This was the first study to imply a role for a constitutive chemokine receptor in renal homeostasis.
7. Rovin BH, Phan LT. Chemotactic factors and renal inflammation. Am J Kidney Dis 1998; 31:1065-1084.
8. Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograff rejection. Immunity 2001; 14:377-386.
9. Annunziato F, Romagnani P, Cosmi L, et al. Chemokines and lymphopoiesis in human thymus. Trends Immunol 2001; 22:277-281.
10. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18:217-242.
11. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14:129-135. This is an excellent review about the chemokines building a bridge between innate and adaptive immunity.
12. Tsuboi N, Yoshikai Y, Matsuo S, et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002; 169:2026-2033. This was the first in-vitro study on the expression of TLRs by tubular epithelial cells and the expression of chemokines through their ligands
13. Chakravorty SJ, Cockwell P, Girdlestone J, et al. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin Exp Immunol 2002; 129:150-159.
14. Zoja C, Donadelli R, Colleoni S, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998; 53:1608-1615.
15. Morigi M, Macconi D, Zoja C, et al. Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 2002; 13:1179-1189. This study adds data to the role of the activation of tubular epithelial cells by proteins and describes involved intracellular signalling pathways.
16. Cockwell P, Calderwood JW, Brooks CJ, et al. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Nephrol Dial Transplant 2002; 17:734-744.
17. Viedt C, Dechend R, Fei J, et al. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1. J Am Soc Nephrol 2002; 13:1534-1547. This was the first study to imply that tubular epithelial cells might not only be the source but also a target for MCP-1.
18. Gilbert RE, Kelly DJ, Atkins RC. Novel approaches to the treatment of progressive renal disease. Curr Opin Pharmacol 2001; 1:183-189.
19. Umekawa T, Chegini N, Khan SR. Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 2002; 61:105-112.
20. Huber TB, Reinhardt HC, Exner M, et al. Expression of functional CCR and CXCR chemokine receptors in podocytes. J Immunol 2002; 168:6244-6252. This was a detailed study on a large number of chemokine receptors unexpectedly expressed by podocytes.
21. Segerer S, Mack M, Regele H, et al. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 1999; 56:52-64.
22. Eitner F, Cui Y, Hudkins KL, Alpers CE. Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection. Transplantation 1998; 66:1551-1557.
23. Romagnani P, Beltrame C, Annunziato F, et al. Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol 1999; 10:2518-2526.
24. Schwarz M, Wahl M, Resch K, Radeke HH. IFNgamma induces functional chemokine receptor expression in human mesangial cells. Clin Exp Immunol 2002; 128:285-294.
25. Banas B, Luckow B, Moller M, et al. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 1999; 10:2314-2322.
26. Segerer S, Cui Y, Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37:518-531.
27. Segerer S, Cui Y, Hudkins KL, et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11:2231-2242.
28. Ito Y, Kawachi H, Morioka Y, et al. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int 2002; 61:2044-2057.
29. Miura M, Fu X, Zhang QW, et al. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 2001; 159:2137-2145. A detailed study that demonstrates the therapeutic impact of chemokine blockade in renal ischemia/reperfusion
30. Grone HJ, Weber C, Weber KS, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. Faseb J 1999; 13:1371-1383.
31. Song E, Zou H, Yao Y, et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002; 61:676-685. This study demonstrated that abrogation of acute allograft rejection through chemokine blocking agents might result in prevention of chronic allograft nephropathy.
32. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74:149-155. This is an excellent recent review on the role of chemokines in renal transplantation (see also Ref. [8]).
33. Anders HJ, Banas B, Schlondorff D, Gröne HJ. Bacterial CpG-DNA aggravates immune complex glomerulonephritis. Role of chemokines and chemokine receptors. J Am Soc Nephrol 2003; 14:317-326. Aggravation of CpG-DNA in a model of immune complex glomerulonephritis implies a new mechanism in which Toll like receptors might mediate flares of renal diseases in men.
34. Segerer S, Hughes E, Hudkins KL, et al. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 2002; 62:488-495. This is the first evaluation of CX3CR1 positive cells in a large number of human renal biopsies.
35. Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO. Fractalkine expression in human renal inflammation. J Pathol 2002; 196:85-90. This study produced the first data on fractalkine in human renal inflammation.
36. Romagnani P, Lazzeri E, Lasagni L, et al. IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 2002; 13:53-64.
37. Hadley TJ, Lu ZH, Wasniowska K, et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994; 94:985-991.
38. Segerer S, Regele H, Mack M, et al. The duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000; 58:1546-1556.
39. Segerer S, Boehmig G, Exner M, et al. When renal allografts turn DARC. Transplantation 2003 (in press).
40. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357:1758-1761.
41. Abdi R, Tran TB, Sahagun-Ruiz A, et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002; 13:754-758. Additional chemokine and receptor polymorphisms and their impact on transplantation outcome were described in this study.
42. Kruger B, Schroppel B, Ashkan R, et al. A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002; 13:2585-2589. This study demonstrated a role for a potentially negative impact of an MCP-1 allele and offers a pathogenetic explanation.
43. Rovin BH, Lu L, Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 2002; 62:261-265.
44. Grone HJ, Cohen CD, Grone E, et al. Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. J Am Soc Nephrol 2002; 13:957-967. This was the first study on the expression of several chemokines and the corresponding receptors during human renal development
45. Ross MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 2002; 13:2997-3004.
46. Bruggeman LA, Ross MD, Tanji N, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11:2079-2087.
47. Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002; 8:522-526.
48. Eitner F, Cui Y, Hudkins KL, et al. Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int 1998; 54:1945-1954.
49. Eitner F, Cui Y, Hudkins KL, et al. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol 2000; 11:856-867.
50. Cohen CD, Grone HJ, Grone EF, et al. Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int 2002; 61:125-132. This important study demonstrated the possibility of quantifying chemokine messenger RNA expression in archival renal biopsies after laser microdissection, which results in new opportunities for future studies.